Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Terumo Corp ADR (OP: TRUMY ) 18.60 -0.45 (-2.34%) Streaming Delayed Price Updated: 3:59 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Terumo Corp ADR Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst January 23, 2024 Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. Via Benzinga Why Shares of Orchestra BioMed Jumped Tuesday September 19, 2023 The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy. Via The Motley Fool Exposures Product Safety Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? March 01, 2023 By David Willey, Benzinga Via TheNewswire.com Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? March 01, 2023 Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? Via News Direct Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? March 01, 2023 The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. Via Benzinga With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO February 15, 2023 Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in... Via Benzinga Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products January 17, 2023 By David Willey, Benzinga Via TheNewswire.com Topics Economy Exposures Supply Chain Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products January 17, 2023 Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products Via News Direct Topics Economy Exposures Supply Chain Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products January 17, 2023 Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the... Via Benzinga Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029 January 12, 2023 EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry January 09, 2023 Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development... Via Benzinga Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure March 07, 2022 Photo by Mockup Graphics on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.